Platelet Rich Plasma Market Intelligence Report - Global Forecast to 2027

Platelet Rich Plasma Market Intelligence Report - Global Forecast to 2027

The Global Platelet Rich Plasma Market is projected to reach USD 609.50 million by 2027 from USD 291.73 million in 2021, at a CAGR 13.06% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Platelet Rich Plasma Market size was estimated at USD 115.63 million in 2021 and expected to reach USD 132.51 million in 2022, at a CAGR 13.06% to reach USD 241.62 million by 2027.
• The Asia-Pacific Platelet Rich Plasma Market size was estimated at USD 66.17 million in 2021 and expected to reach USD 77.49 million in 2022, at a CAGR 13.86% to reach USD 144.22 million by 2027.
• The Europe, Middle East & Africa Platelet Rich Plasma Market size was estimated at USD 109.92 million in 2021 and expected to reach USD 124.28 million in 2022, at a CAGR 12.56% to reach USD 223.65 million by 2027.

Market Segmentation & Coverage:

The report on platelet rich plasma identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the platelet rich plasma to forecast the revenues and analyze the trends in each of the following sub-markets:

Source Type:

• Allogenic
• Autologous
• Homologous

Application:

• Cosmetic Surgery
• General Surgery
• Neurosurgery
• Orthopedic Surgery

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• APEX Biologix, LLC
• Arthrex, Inc.
• Biotest AG
• Celling Biosciences, Inc.
• China Biologic Products Holdings, Inc.
• CSL Limited
• Dr PRP USA LLC
• Eclipse
• EmCyte Corporation
• Estar Technologies Ltd.
• Exactech, Inc.
• Glofinn Oy
• Johnson & Johnson
• Juventix Regenerative Medical, LLC
• Stryker Corporation
• Terumo BCT, Inc.
• ThermoGenesis Holdings, Inc.
• Zimmer Biomet Holdings, Inc.